• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION VIRTUOSAPH PLUS WITH RADIAL INDICATION; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION VIRTUOSAPH PLUS WITH RADIAL INDICATION; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES Back to Search Results
Model Number VSP550EX
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Terumo will not receive the device for evaluation; however, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.For this reason, terumo references evaluation conclusion code 11.
 
Event or Problem Description
During the periodic risk review for vsp550ex product, a maude database search was performed, and a complaint was found that was not reported to tcvs.An elderly male with history of poor circulation of right lower extremity.Procedure was right iliofemoral endarterectomy with iliac stenting and right femoral to posterior tibial bypass.While they were cauterizing, the tip of the device broke off.They were able to be removed from the patient and no known harm to patient.
 
Additional Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on june 26, 2025.Upon further investigation of the reported event, the following information is new and/or changed: g.3.(date received by manufacturer).G.6.(indication that this is a follow-up report).H.2.(follow-up due to additional information).H.6.(identification of evaluation codes 11, 3331, 4114, 3221, 4315).The affected sample was not returned; therefore, a thorough investigation could not be performed.A retention sample from the same lot number was inspected to show no anomalies with the device and a fully intact v-cutter.Without a returned device, a definitive root cause could not be determined.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIRTUOSAPH PLUS WITH RADIAL INDICATION
Common Device Name
ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
Manufacturer (Section G)
SAME
Manufacturer Contact
douglas patton
125 blue ball road
elkton, MD 21921
7346634145
MDR Report Key22342449
Report Number1124841-2025-00054
Device Sequence Number4825719
Product Code GEI
UDI-Device Identifier00699753450769
UDI-Public(01)00699753450769(17)260831(10)39K
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K160206
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 08/25/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/31/2026
Device Model NumberVSP550EX
Device Catalogue NumberN/A
Device Lot Number39K
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/09/2025
Supplement Date Received by Manufacturer08/01/2025
Initial Report FDA Received Date06/26/2025
Supplement Report FDA Received Date08/25/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexMale
-
-